Home > Insider Trading > Filing (0001179110-11-015559)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Synta Pharmaceuticals Corp	SNTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325713	Bruce Kovner	C/O Caxton Associates Lp 500 Park Avenue New York NY 10022		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-18	21,000	$3.71	5,183,126	No	4	P	Direct
Common Stock	Acquisiton	2011-11-21	33,640	$3.84	5,216,766	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,761,716	Indirect	By CxSynta LLC

Footnotes

The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.80 per share. The price reported above is the weighted average purchase price. See footnote (4)
The shares were purchased in multiple transactions at prices ranging from $3.76 to $3.98 per share. The price reported above is the weighted average purchase price. See footnote (4)
These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as Chairman of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.